Clinical Trials Logo

Filter by:
NCT ID: NCT05869383 Completed - Sarcopenia Clinical Trials

Effect Of Ophiochepalus Striatus Extract On Serum IGF-1 And IL-6 Levels In Elderly Patients With Sarcopenia

Start date: May 1, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The goal of this Clinical Trial is to analyze effect of Ophiochepalus striatus extract on serum IGF-1 and IL-6 levels in elderly patients with sarcopenia. The main questions it aims to answer are: 1. Can giving Ophiocephalus striatus extract at a dose of 2x5 grams for 2 weeks increase IGF-1 levels in elderly people with sarcopenia? 2. Can administration of 2x5 grams dose of Ophiocephalus striatus extract for 2 weeks reduce IL-6 levels in elderly with sarcopenia? 3. Can the administration of Ophiocephalus striatus extract at a dose of 2x5 grams for 2 weeks reduce the SARC-F score in elderly people with sarcopenia? 4. Can the administration of Ophiocephalus striatus extract at a dose of 2x5 grams for 2 weeks increase muscle mass in elderly people with sarcopenia? 5. Can the administration of Ophiocephalus striatus extract at a dose of 2x5 grams for 2 weeks increase muscle strength in elderly people with sarcopenia? 6. Can administration of Ophiocephalus striatus extract at a dose of 2x5 grams for 2 weeks improve physical performance in elderly with sarcopenia? Participants will: 1. Consume Ophiochepalus striatus extract 2x5 grams a day. 2. Checked blood before and after the intervention. 3. Measured muscle mass, muscle strength, and physical performance before and after the intervention.

NCT ID: NCT05867043 Recruiting - Surgery Clinical Trials

Postoperative Gastrointestinal Dysfunction After High Risk Surgery

Start date: January 23, 2023
Phase:
Study type: Observational

This study aims to find out the role of plasma I-FABP level, SOFA score, fluid balance, and vasopressor dose in predicting gastrointestinal dysfunction in high-risk postoperative patients treated in ICU

NCT ID: NCT05866276 Active, not recruiting - Clinical trials for Chronic Kidney Disease

To Determine the Accuracy of SCreening for Occult REnal Disease (SCORED) Questionnaire for CKD Risk Among Asian Patients

SCREEN
Start date: June 22, 2023
Phase:
Study type: Observational

To determine the accuracy of SCreening for Occult REnal Disease (SCORED) questionnaire for CKD risk among Asian Patients

NCT ID: NCT05861687 Completed - Clinical trials for Helicobacter Pylori Infection

Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children

Start date: August 1, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

This study aims to compare the recurrence rates of Esomeprazole and Lansoprazole in triple combination therapy to eradicate H.pylori infection in children. The participants were divided into two groups, those who received Esomeprazole and those who received Lansoprazole

NCT ID: NCT05861310 Not yet recruiting - Rosacea Clinical Trials

Effectivity and Safety of Metronidazole 1% Cream in Rosacea Therapy

Start date: May 2023
Phase: Phase 1
Study type: Interventional

Rosacea is a chronic inflammatory disease of the central facial region, which can also occur in the neck and chest regions. Microbes that play a role in rosacea are Demodex folliculorum and Helicobactor pylori. On the skin with rosacea have decreased skin barrier function. This clinical study will compare the effectiveness and safety of metronidazole 1% cream as the main therapy in rosacea patients. Participants who will become research subjects are women and men aged 18-60 years who meet the inclusion criteria. Research subjects were divided into 2 groups. The control group will use placebo cream (without the drug substance) and the comparison group will use metronidazole 1% cream.

NCT ID: NCT05856292 Completed - Cancer Pain Clinical Trials

Improving Cancer Pain Management Through Teach-Back Educational Approach for Patients and Primary Caregivers: A Pilot Study

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

This randomized prospective quantitative pilot study compared teach-back method to standardized educational method in patient and caregiver to improve cancer pain management

NCT ID: NCT05851625 Completed - Chemotherapy Effect Clinical Trials

Efficacy of Ear Acupuncture in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients

Start date: October 16, 2023
Phase: N/A
Study type: Interventional

Chemotherapy is a cancer therapy performed on advanced cancer with quite good success, but this therapy has quite a lot of side effects. Chemotherapy induced nausea and vomiting or commonly known as CINV, is a condition of nausea and vomiting experienced by cancer patients undergoing chemotherapy, with a prevalence of around 80% of all patients undergoing chemotherapy, and 40% has the potential to become severe. This study aims to determine the efficacy of a new acupuncture modality, namely the press needle, in preventing CINV symptoms in pediatric patients with cancer undergoing chemotherapy.

NCT ID: NCT05850949 Not yet recruiting - Diet, Healthy Clinical Trials

The Effect of Konjac Grain in the Post-prandial Glycaemic Response of Healthy Subjects

Konjac
Start date: May 10, 2023
Phase: N/A
Study type: Interventional

determine the effect of giving the Konjac-Grain formula as a mixture of white rice in suppressing post-prandial glucose absorption.

NCT ID: NCT05849883 Completed - Drug Use Clinical Trials

Bioequivalence Study of 20 mg Omeprazole Capsules in Indonesia Healthy Subject

Start date: December 10, 2020
Phase: N/A
Study type: Interventional

The study was conducted to investigate whether 20 mg omeprazole capsules manufactured by PT. Dankos Farma for PT. Hexpharm Jaya is bioequivalent to its reference product, 20 mg Losec® capsules manufactured by AstraZeneca AB, Sweden, imported by PT. AstraZeneca Indonesia.

NCT ID: NCT05844904 Active, not recruiting - Clinical trials for Baumann Skin Type Indicator

Mapping of Indonesians' Skin Type Based on Baumann Skin Type Indicator-Indonesia and Development of Artificial Intelligence Modelling

Start date: September 8, 2023
Phase:
Study type: Observational

The goal of this observational study is to learn about the skin type of Indonesians based on Baumann Skin Type Indicator Questionnaire in Indonesian language version, and to develop artificial intelligence modelling of BSTI-Ina. The main questions it aims to answer are: 1. What is the measurement of the validity and reliability of BSTI-Ina questionnaire year 2006 version which was adapted from BSTI questionnaire in English language year 2006 version as a specific measurement to identify skin type? 2. What is the measurement of the validity and reliability of BSTI-Ina questionnaire year 2022 version which was adapted from BSTI questionnaire in English language year 2022 version as a specific measurement to identify skin type? 3. What is the comparison of the validity and reliability between BSTI-Ina questionnaire year 2006 and year 2022 to determine Indonesian adult population's skin type? 4. How is the mapping of Indonesians' skin type based on BSTI-Ina? 5. What is the proportion of each skin type based on BSTI-Ina in Indonesian population? 6. What is the proportion of each skin type based on BSTI-Ina in Indonesian population sociodemographically? 7. How can Artificial Intelligence help categorize skin type based on BSTI-Ina automatically? Participants are males and females between 18-59 year old. Participants will be asked to fill BSTI-Ina questionnaire. Participants then will be photographed in five different positions.